[{"Assets_0_Q3_USD":44439729.0,"CommonStockSharesOutstanding_0_Q3_shares":34496846.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-28807908.0,"NetIncomeLoss_1_Q3_USD":-19135612.0,"NetIncomeLoss_3_Q3_USD":-43538202.0,"StockholdersEquity_0_Q3_USD":6822596.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]